• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国-墨西哥边境城市中,西班牙裔肺动脉高压患者健康的社会决定因素对生存结果的复杂相互作用。

Complex Interactions of Social Determinants of Health on Survival Outcomes in Hispanic Patients With Pulmonary Arterial Hypertension in a US-Mexican Border City.

作者信息

Algheriani Hedaia, Cazares-Parson Marco, Brockman Michael, Zakhireh Bobak, Srinivas Sunil, Mukherjee Debabrata, Dwivedi Alok K, Nickel Nils P

机构信息

Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA.

Paul L. Foster School of Medicine, El Paso, TX, USA.

出版信息

Cardiol Res. 2025 Jun;16(3):189-196. doi: 10.14740/cr1748. Epub 2025 Apr 22.

DOI:10.14740/cr1748
PMID:40370622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12074678/
Abstract

BACKGROUND

Pulmonary arterial hypertension (PAH) is a chronic disease of the pulmonary blood vessels that can lead to right heart failure, resulting in increased morbidity and mortality if left untreated. While right heart hemodynamics and functional capacity are a well-established predictors of outcome in PAH, emerging evidence suggests that social determinants of health (SDOH) may have a significant impact on patients with PAH, influencing outcomes and survival rates. This study explores the impact of SDOH and their intricate interactions on survival among a Hispanic patient cohort along the US-Mexico border.

METHODS

A retrospective analysis was conducted on a single-center cohort of 158 PAH patients (72% female, mean age 58 years) using Cox proportional hazards models and latent class analyses. The primary outcome was mortality during the follow-up period, with secondary analyses examining the impact of individual and combined SDOH on survival.

RESULTS

During a mean follow-up period of 3.8 years (range: 0.2 to 6 years), 37 patients (23.4%) died. Lack of health insurance (hazard ratio (HR) 2.17; 95% confidence interval (CI): 1.05 - 4.49, P = 0.037) and unemployment (HR 2.99; 95% CI: 1.42 - 6.30, P = 0.004) were significantly associated with a higher risk of death within 5 years of follow-up. Latent variable modeling revealed that patients aged ≥ 60 years, who were uninsured, unmarried, and unemployed along with greater PAH severity (measured with cardiac output, mean pulmonary arterial pressure, six-minute walk distance, and World Health Organization Functional Class > 2) had the highest risk of poor outcomes (HR 3.6, 95% CI: 1.9 - 6.8, P < 0.001). Interestingly, the type of insurance did not have a significant impact on survival.

CONCLUSION

The findings underscore the critical need for improved access to insurance coverage and enhanced social support to promote better health outcomes among this vulnerable Hispanic population. Addressing these SDOH is essential in closing the health disparity gap and improving survival rates in PAH patients.

摘要

背景

肺动脉高压(PAH)是一种肺部血管的慢性疾病,可导致右心衰竭,若不治疗,发病率和死亡率会增加。虽然右心血流动力学和功能能力是PAH预后的既定预测指标,但新出现的证据表明,健康的社会决定因素(SDOH)可能对PAH患者有重大影响,影响预后和生存率。本研究探讨了SDOH及其复杂相互作用对美墨边境西班牙裔患者队列生存率的影响。

方法

使用Cox比例风险模型和潜在类别分析,对一个单中心队列的158名PAH患者(72%为女性,平均年龄58岁)进行回顾性分析。主要结局是随访期间的死亡率,次要分析考察个体和综合SDOH对生存的影响。

结果

在平均3.8年(范围:0.2至6年)的随访期内,37名患者(23.4%)死亡。缺乏医疗保险(风险比(HR)2.17;95%置信区间(CI):1.05 - 4.49,P = 0.037)和失业(HR 2.99;95%CI:1.42 - 6.30,P = 0.004)与随访5年内较高的死亡风险显著相关。潜在变量模型显示,年龄≥60岁、未参保、未婚、失业且PAH严重程度更高(用心输出量、平均肺动脉压、六分钟步行距离和世界卫生组织功能分级>2衡量)的患者预后不良风险最高(HR 3.6,95%CI:1.9 - 6.8,P < 0.001)。有趣的是,保险类型对生存没有显著影响。

结论

研究结果强调迫切需要改善保险覆盖范围和加强社会支持,以促进这一脆弱西班牙裔人群获得更好的健康结局。解决这些SDOH对于缩小健康差距和提高PAH患者的生存率至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0de7/12074678/c433c9a4ede0/cr-16-03-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0de7/12074678/7d5e77973481/cr-16-03-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0de7/12074678/c433c9a4ede0/cr-16-03-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0de7/12074678/7d5e77973481/cr-16-03-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0de7/12074678/c433c9a4ede0/cr-16-03-189-g002.jpg

相似文献

1
Complex Interactions of Social Determinants of Health on Survival Outcomes in Hispanic Patients With Pulmonary Arterial Hypertension in a US-Mexican Border City.美国-墨西哥边境城市中,西班牙裔肺动脉高压患者健康的社会决定因素对生存结果的复杂相互作用。
Cardiol Res. 2025 Jun;16(3):189-196. doi: 10.14740/cr1748. Epub 2025 Apr 22.
2
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.西班牙裔种族与肺动脉高压健康的社会决定因素:肺动脉高压协会登记研究
Ann Am Thorac Soc. 2022 Sep;19(9):1459-1468. doi: 10.1513/AnnalsATS.202109-1051OC.
3
The Association Between Non-Clinically Apparent Liver Fibrosis and Pulmonary Arterial Hypertension in Hispanic Patients.西班牙裔患者非临床显性肝纤维化与肺动脉高压之间的关联
Cardiol Res. 2023 Dec;14(6):429-436. doi: 10.14740/cr1565. Epub 2023 Dec 9.
4
[Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].[先天性心脏病相关肺动脉高压患者不同亚型的死亡危险因素及临床特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):315-322. doi: 10.3760/cma.j.cn112148-20190628-00364.
5
Phosphodiesterase 5 inhibitors for pulmonary hypertension.用于治疗肺动脉高压的磷酸二酯酶5抑制剂。
Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD012621. doi: 10.1002/14651858.CD012621.pub2.
6
Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.脉动血流动力学参数可预测儿科肺动脉高压患者的生存情况。
Int J Cardiol. 2013 Sep 30;168(2):1370-7. doi: 10.1016/j.ijcard.2012.12.080. Epub 2013 Jan 20.
7
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).预测肺动脉高压患者的生存情况:来自评估早期和长期肺动脉高压疾病管理登记研究(REVEAL)的见解。
Circulation. 2010 Jul 13;122(2):164-72. doi: 10.1161/CIRCULATIONAHA.109.898122. Epub 2010 Jun 28.
8
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.初始治疗后随访血流动力学变量对肺动脉高压的预后价值。
Circulation. 2018 Feb 13;137(7):693-704. doi: 10.1161/CIRCULATIONAHA.117.029254. Epub 2017 Oct 25.
9
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.系统性硬皮病相关肺动脉高压的生存和死亡预测因素:从肺动脉高压评估和硬皮病登记处识别结果中得出的结果。
Arthritis Care Res (Hoboken). 2014 Mar;66(3):489-95. doi: 10.1002/acr.22121.
10
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.结缔组织病相关肺动脉高压患者死亡率的预测因素:一项队列研究。
Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

本文引用的文献

1
Pathophysiology of the right ventricle and its pulmonary vascular interaction.右心室的病理生理学及其与肺血管的相互作用。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01321-2024. Print 2024 Oct.
2
Pathology and pathobiology of pulmonary hypertension: current insights and future directions.肺动脉高压的病理学和病理生物学:当前的认识和未来的方向。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01095-2024. Print 2024 Oct.
3
Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.肺动脉高压各阶段的健康相关生活质量。
Chest. 2024 Jun;165(6):1493-1504. doi: 10.1016/j.chest.2024.02.009. Epub 2024 Feb 12.
4
Analysis of social determinants of health and individual factors found in health equity frameworks: Applications to injury research.健康公平框架中分析健康的社会决定因素和个体因素:在伤害研究中的应用。
J Safety Res. 2023 Dec;87:508-518. doi: 10.1016/j.jsr.2023.10.001. Epub 2023 Oct 18.
5
Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models.西班牙裔肺动脉高压患者群体的预后:常见风险分层模型的应用
Pulm Circ. 2023 Apr 1;13(2):e12209. doi: 10.1002/pul2.12209. eCollection 2023 Apr.
6
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
7
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.通过健康的社会决定因素预测患者预后:肺动脉高压协会注册研究(PHAR)评估
Pulm Circ. 2022 Jul 1;12(3):e12120. doi: 10.1002/pul2.12120. eCollection 2022 Jul.
8
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.西班牙裔种族与肺动脉高压健康的社会决定因素:肺动脉高压协会登记研究
Ann Am Thorac Soc. 2022 Sep;19(9):1459-1468. doi: 10.1513/AnnalsATS.202109-1051OC.
9
Pulmonary Arterial Hypertension: What Rare Diseases Tell Us About Disparities in Disease Registries, Clinical Trials, and Treatment Algorithms.肺动脉高压:罕见疾病对疾病登记、临床试验和治疗算法差异的启示
Chest. 2021 Nov;160(5):1981-1983. doi: 10.1016/j.chest.2021.06.010.
10
Social Determinants of Health and Geographic Variation in Medicare per Beneficiary Spending.医疗保险受益人均支出的健康社会决定因素和地域差异。
JAMA Netw Open. 2021 Jun 1;4(6):e2113212. doi: 10.1001/jamanetworkopen.2021.13212.